Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

time points and study design [Design Issues]

posted by drmuneesh – 2009-04-02 13:10 (6294 d 12:04 ago) – Posting: # 3452
Views: 3,883

Dear MGR

Thank you for the guidance. Can you please suggest the time points and safety of 150 mg dose in healthy human subjects.

Regards

Dr Muneesh Garg

Complete thread:

time points and study design drmuneesh 2009-03-31 11:04
- time points and study design MGR 2009-04-01 08:18
  - time points and study designdrmuneesh 2009-04-02 11:10
    - selection of time points martin 2009-04-03 08:45
      - selection of time points drmuneesh 2009-04-03 09:42
        
        BE study? martin 2009-04-04 19:40
        
        BE study. Ohlbe 2009-04-04 23:38

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
344 visitors (0 registered, 344 guests [including 21 identified bots]).
Forum time: 01:15 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge. Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz